Verona Pharma plc's Ohtuvayre, approved for COPD, has driven the Pharma's stock up >350%, but intense competition and high valuation prompted a downgrade to “Hold”. Despite early success ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster. The first-in-class dual ...

Five years ago, a respiratory virus, COVID-19, began to descend on Verona. Before vaccinations brought it to its knees, COVID would become the third leading cause of death here, with 23 fatalities.

After hours: March 14 at 7:56:19 PM EDT Loading Chart for VRNA ...

After hours: March 14 at 7:59:42 PM EDT Loading Chart for GEV ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...